(Total Views: 186)
Posted On: 06/19/2018 1:47:08 PM
Post# of 72721
$AMBS ’ wholly-owned subsidiary MANF Therapeutics, Inc. owns key intellectual property rights and licenses from a number of prominent universities related to the development of the therapeutic protein known as mesencephalic astrocyte-derived neurotrophic factor (MANF).
https://financialstrend.com/two-themes-could-...46629.html
https://financialstrend.com/two-themes-could-...46629.html
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
Scroll down for more posts ▼
